Skip to content


Arthritis Research & Therapy

Open Access

Sustained high expression of Fcγ receptorII (CD32) on dendritic cells (DCs) in patients with rheumatoid arthritis (RA)

  • TRDJ Radstake1,
  • A Blom1,
  • E van Gorselen1,
  • L Engelen2,
  • G Adema2,
  • P van Lent1,
  • P Barrera1,
  • C Figdor2 and
  • W van den Berg
Arthritis Research & Therapy20024(Suppl 1):43

Received: 15 January 2002

Published: 4 February 2002


Rheumatoid ArthritisPeripheral Blood Mononuclear CellRheumatoid Arthritis PatientCD32 ExpressionSynovial Tissue


DCs are professional antigen presenting cells. For antigen internalisation, DCs use the Fcγ receptorII (CD32) which recognises anti-IgG-complexes and therefore might be involved in regulation of autoimmunity. Normally, CD32 is abundantly expressed on immature DCs and down-regulated after full maturation.


Evaluation of CD32 expression on DCs from RA patients.


Peripheral blood mononuclear cells obtained from RA patients and healthy donors were cultured with GM-CSF and IL-4 for 6 days to obtain immature DCs. Stimulation with LPS from day 6 yielded mature DCs at day 8. The expression of surface markers involved in T cell-DC interaction (DC-SIGN, CD83) antigen uptake (FcγRI, IIandIII) and presentation (CD80, CD86, MHC-I and MHC-II) were studied using FACS analysis. In addition, RT-PCR and in vivo colocalisation studies using DC-specific markers in synovium were used to confirm these findings.


In both RA patients and controls DCs expressed expected levels of CD80, CD86, CD83, MHC-I, MHC-II and DC-SIGN. Interestingly, immature DCs showed a threefold increase in expression of CD32 when compared with controls (mean fluorescence 185.8 vs. 63.0 P < 0.01). Moreover, this increased expression of CD32 is sustained in fully mature DCs from RA patients (mean fluorescence 452.3 vs. 187.8 P = 0.005), whereas CD32 expression is strongly down-regulated upon maturation of DCs from controls. The sustained high expression of CD32 was further confirmed by RT-PCR. Both FcγRIIa and FcγRIIb were increased in immature DCs as well as mature DC from RA patients but not in DCs from healthy controls. In RA both immature and mature DCs showed a balance towards FcγRIIb. Colocalisation between FcγRII and DC-LAMP and DC-CK1 was clearly observed in RA synovial tissue.


Both immature and mature DCs from RA patients showed a significant increased expression of the FcγRII suggestive for an aberrant maturation pathway. In vivo, mature DCs with a high FcγRII expression are clearly present in the synovium in RA. These findings are suggestive for a crucial role of high FcγRII expression on DCs in synovial tissue in promoting and sustaining the local immune response in RA.

Authors’ Affiliations

University Medical Center Nijmegen, Nijmegen, The Netherlands
Tumor Immunology Laboratory, Nijmegen, The Netherlands


© BioMed Central Ltd 2002